Relay Therapeutics, Inc. Common Stock
Symbol: RLAY (NASDAQ)
Company Description:
Relay Therapeutics Inc is a clinical-stage precision medicine company transforming the drug discovery process by combining leading-edge computational and experimental technologies with the goal of bringing life-changing therapies to patients. the Dynamo platform integrates an array of leading-edge computational and experimental approaches designed to drug-protein targets that have previously been intractable or inadequately addressed. The company is advancing a pipeline of medicine candidates to address targets in precision oncology and genetic disease, including product candidates, RLY-4008, RLY-2608, and GDC-1971 (formerly known as RLY-1971).
- Today's Open: $6.47
- Today's High: $6.824
- Today's Low: $6.324
- Today's Volume: 1.51M
- Yesterday Close: $6.48
- Yesterday High: $7
- Yesterday Low: $6.445
- Yesterday Volume: 1.99M
- Last Min Volume: 10
- Last Min High: $6.76
- Last Min Low: $6.76
- Last Min VWAP: $6.76
- Name: Relay Therapeutics, Inc. Common Stock
- Website: https://www.relaytx.com
- Listed Date: 2020-07-16
- Location: CAMBRIDGE, MA
- Market Status: Active
- CIK Number: 0001812364
- SIC Code: 2836
- SIC description: BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
- Market Cap: $1.21B
- Round Lot: 100
- Outstanding Shares: 172.41M
- Asset Type: CS
Filing Date | Filing Type | Format |
---|---|---|
2025-08-14 | SCHEDULE 13G/A | View |
2025-08-14 | SCHEDULE 13G/A | View |
2025-08-07 | 10-Q | View |
2025-08-07 | 8-K | View |
2025-07-30 | 4 | View |
2025-07-30 | 4 | View |
2025-07-30 | 4 | View |
2025-07-30 | 4 | View |
2025-07-29 | SCHEDULE 13G/A | View |
2025-07-10 | 4 | View |
2025-07-01 | 4 | View |
2025-07-01 | 4 | View |
2025-06-11 | 4 | View |
2025-06-11 | 3 | View |
2025-06-11 | 8-K | View |
2025-06-06 | 4 | View |
2025-06-06 | 4 | View |
2025-06-06 | 4 | View |
2025-06-06 | 4 | View |
2025-06-06 | 4 | View |